Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Eschbach · SciRah

Researcher profile · Semantic Scholar

C. Eschbach

Share profile

C. Eschbach — researcher profile on SciRah

h-index: 12
Works: 27
Citations: 728

Most-cited papers

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.
K. O'Byrne, U. Gatzemeier, I. Bondarenko, C. Barrios +14 more
2011The Lancet Oncology212 citations
Semantic Scholar
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer.
M. Reck, R. Kaiser, C. Eschbach, M. Stefanic +4 more
2011Annals of Oncology151 citations Open access
Semantic Scholar
Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC): Data from the FLEX study.
K. O'Byrne, I. Bondarenko, C. Barrios, C. Eschbach +6 more
2016Journal of Clinical Oncology104 citations
Semantic Scholar
A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.
W. Schuette, A. Gröschel, M. Sebastian, S. Andreas +7 more
2013Clinical Lung Cancer46 citations
Semantic Scholar
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non‐small cell lung cancer
A. Atmaca, S. Al-Batran, R. Wirtz, D. Werner +8 more
2014International Journal of Cancer33 citations Open access
Semantic Scholar
A longitudinal communication approach in advanced lung cancer: A qualitative study of patients’, relatives’ and staff's perspectives
M. Villalobos, Kadiatou Coulibaly, K. Krug, Martina Kamradt +9 more
2018European Journal of Cancer Care28 citations Open access
Semantic Scholar
Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer
P. Jänne, L. Paz-Ares, Y. Oh, C. Eschbach +4 more
2014Journal of Thoracic Oncology25 citations Open access
Semantic Scholar
Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: data from a multicenter cohort study
W. Siemens, S. Schönsteiner, C. L. Orellana-Rios, U. Schaekel +6 more
2020Supportive Care in Cancer23 citations Open access
Semantic Scholar
Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany.
M. Reck, R. Stahel, J. von Pawel, M. Karthaus +7 more
2010Respiratory Medicine19 citations Open access
Semantic Scholar
A double blind phase II study of BIBF 1,120 in patients suffering from relapsed advanced non-small cell lung cancer (NSCLC)
J. von Pawel, R. Kaiser, C. Eschbach, M. Stefanic +3 more
200719 citations
Semantic Scholar
Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-II Study
G. Scagliotti, Robert Ilaria, S. Novello, J. von Pawel +8 more
2012Journal of Thoracic Oncology16 citations Open access
Semantic Scholar
A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
J. Vansteenkiste, R. Ramlau, J. von Pawel, B. San Antonio +6 more
2012Oncology15 citations
Semantic Scholar
6568 POSTER Phase II trial of the novel epothilone ZK-EPO as second-line therapy in patients with stage IIIB or stage IV non-small-cell lung cancer
U. Gatzemeier, J. von Pawel, C. Eschbach, A. Brune +3 more
200712 citations
Semantic Scholar
Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer.
D. Heigener, J. von Pawel, C. Eschbach, A. Brune +4 more
2013Lung Cancer11 citations
Semantic Scholar
Feasibility of cetuximab in combination with gemcitabine or docetaxel or carboplatin/gemcitabine for chemonaive patients with advanced non-small cell lung cancer (NSCLC): Observations from an ongoing randomized phase II/III trial (GemTax IV)
L. Pilz, S. Cicėnas, C. Eschbach, J. Fischer +5 more
20083 citations
Semantic Scholar
Influence of expression of estrogen (ERS-1) and progesterone (PGR) receptors on metastatic spread and outcome in non-small cell lung cancer (NSCLC).
W. Brueckl, C. Eschbach, G. Wiest, J. Ficker +5 more
2011Journal of Clinical Oncology2 citations
Semantic Scholar
9152 A population pharmacokinetic analysis for BIBF 1120, an angiokinase inhibitor, in patients with advanced non-small cell lung cancer
P. Stopfer, M. Freiwald, K. Liesenfeld, R. Bruno +6 more
20092 citations
Semantic Scholar
A population pharmacokinetic analysis for BIBF 1120, an angiokinase inhibitor, in patients with advanced non-small-cell lung cancer (NSCLC)
M. Freiwald, K. Liesenfeld, R. Bruno, L. Hodge +6 more
20082 citations
Semantic Scholar
Frühe palliative Intervention
C. Eschbach, D. Heigener, W. Nehls, M. Villalobos +1 more
2015Wiener klinisches Magazin1 citations
Semantic Scholar
Frühe palliative Intervention
C. Eschbach, David F. Heigener, W. Nehls, M. Villalobos +1 more
2014Der Onkologe1 citations
Semantic Scholar
Early Palliative Care in Real-World Clinical Practice: Effectiveness Regarding Quality of Life and Symptoms of Newly Diagnosed Advanced Cancer Outpatients in Comprehensive Cancer Centres - A Multicentre, Mixed-Methods, Sequential Control Group Study (EVI Project)
W. Siemens, C. L. Orellana-Rios, S. Schönsteiner, U. Schaekel +5 more
2019Social Science Research Network0 citations Open access
Semantic Scholar
Cetuximab combined with either gemcitabine (G) followed by docetaxel (D) or carboplatin/gemcitabine (CP/G) in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC): Safety profile from the ongoing phase II/III GemTax IV trial.
M. Serke, L. Pilz, S. Cicėnas, C. Eschbach +5 more
2016Journal of Clinical Oncology0 citations
Semantic Scholar
Pulmonary toxicity in patients treated with a combination of gemcitabine (G) associated to docetaxel (D) or vinorelbine (V) for advanced non-small cell lung cancer (NSCLC): outcome data on a randomized phase II study: P2-254
C. Eschbach, Pilz, Thatcher, Nicholas +16 more
20150 citations
Semantic Scholar
The EGFR-targeting chimeric monoclonal IgG-1 antibody cetuximab (CTX) added either to gemcitabine (G) followed by docetaxel (D) or carboplatin/gemcitabine (CP/G) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC): Preliminary safety results of the ongoing GemTax IV trial.
C. Manegold, S. Cicėnas, C. Eschbach, J. Kollmeier +6 more
20100 citations
Semantic Scholar
9144 Cetuximab in combination with gemcitabine/docetaxel or carboplatin/gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: toxicity data from an ongoing Phase II/III trial (GemTax IV)
C. Schumann, L. Pilz, S. Cicėnas, C. Eschbach +5 more
20090 citations
Semantic Scholar
9077 Phase 2 study of pemetrexed and cisplatin plus either enzastaurin or placebo in chemonaive patients with advanced NSCLC
M. Reck, R. Ramlau, J. von Pawel, B. S. Antonio +5 more
20090 citations
Semantic Scholar
P2-252: Analyses of clinical prognostic factors in the treatment of advanced non-small cell lung cancer (NSCLC): Cox regression analysis based on 789 patients from three consecutive randomized Phase II trials using gemcitabine and docetaxel
C. Eschbach, L. Pilz, N. Thatcher, C. Kortsik +3 more
20070 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. von Pawel×12
Invite
J. von Pawel — researcher profile on SciRah
M. Reck×10
Invite
M. Reck — researcher profile on SciRah
C. Kortsik×7
Invite
C. Kortsik — researcher profile on SciRah
L. Pilz×5
Invite
L. Pilz — researcher profile on SciRah

×4

Invite

R. Kaiser — researcher profile on SciRah

Invite

C. Manegold — researcher profile on SciRah

Invite

S. Cicėnas — researcher profile on SciRah

Invite

C. Schumann — researcher profile on SciRah

Invite

M. Steins — researcher profile on SciRah

U. Gatzemeier×3

Invite

U. Gatzemeier — researcher profile on SciRah

Invite

R. Ramlau — researcher profile on SciRah

Invite

P. Stopfer — researcher profile on SciRah